OVID – Ovid Therapeutics Inc.
OVID — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
13.05
Margin Of Safety %
Put/Call OI Ratio
0.24
EPS Next Q Diff
0.01
EPS Last/This Y
-0.21
EPS This/Next Y
Price
2.62
Target Price
5.75
Analyst Recom
1
Performance Q
-3.66
Upside
-218.6%
Beta
0.25
Ticker: OVID
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-07-13 | OVID | 2.42 | 0.44 | 3.13 | 5314 |
| 2026-07-14 | OVID | 2.44 | 0.48 | 0.25 | 5481 |
| 2026-07-15 | OVID | 2.5 | 0.48 | 3.00 | 5486 |
| 2026-07-16 | OVID | 2.45 | 0.49 | 1.64 | 5501 |
| 2026-07-17 | OVID | 2.43 | 0.50 | 0.46 | 5536 |
| 2026-07-20 | OVID | 2.31 | 0.44 | 0.01 | 3788 |
| 2026-07-21 | OVID | 2.41 | 0.27 | 0.00 | 4747 |
| 2026-07-22 | OVID | 2.38 | 0.21 | 0.00 | 5787 |
| 2026-07-23 | OVID | 2.39 | 0.21 | 0.00 | 5787 |
| 2026-07-24 | OVID | 2.33 | 0.21 | 0.00 | 5787 |
| 2026-07-27 | OVID | 2.36 | 0.21 | 0.00 | 5863 |
| 2026-07-28 | OVID | 2.36 | 0.21 | 0.00 | 5863 |
| 2026-07-29 | OVID | 2.28 | 0.21 | 0.00 | 5863 |
| 2026-07-30 | OVID | 2.37 | 0.21 | 999.99 | 5865 |
| 2026-07-31 | OVID | 2.2 | 0.21 | 0.00 | 5865 |
| 2026-08-03 | OVID | 2.33 | 0.21 | 0.05 | 5865 |
| 2026-08-04 | OVID | 2.55 | 0.21 | 1.07 | 5854 |
| 2026-08-05 | OVID | 2.62 | 0.21 | 1.41 | 5869 |
| 2026-08-06 | OVID | 2.66 | 0.23 | 10.00 | 6042 |
| 2026-08-07 | OVID | 2.62 | 0.24 | 18.67 | 6125 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-07-13 | OVID | 2.42 | -73.8 | -26.1 | -0.44 |
| 2026-07-14 | OVID | 2.45 | -73.8 | -31.2 | -0.44 |
| 2026-07-15 | OVID | 2.50 | -73.8 | -33.1 | -0.44 |
| 2026-07-16 | OVID | 2.46 | -73.8 | -28.4 | -0.44 |
| 2026-07-17 | OVID | 2.43 | -73.8 | -29.2 | -0.44 |
| 2026-07-20 | OVID | 2.31 | -73.8 | -24.0 | -0.44 |
| 2026-07-21 | OVID | 2.40 | -73.8 | -35.4 | -0.44 |
| 2026-07-22 | OVID | 2.38 | -73.8 | -28.8 | -0.44 |
| 2026-07-23 | OVID | 2.39 | -73.8 | -31.0 | -0.44 |
| 2026-07-24 | OVID | 2.32 | -73.8 | -26.3 | -0.44 |
| 2026-07-27 | OVID | 2.36 | -73.8 | -31.9 | -0.44 |
| 2026-07-28 | OVID | 2.36 | -73.8 | -30.7 | -0.44 |
| 2026-07-29 | OVID | 2.29 | -73.8 | -26.6 | -0.44 |
| 2026-07-30 | OVID | 2.36 | -73.8 | -33.8 | -0.44 |
| 2026-07-31 | OVID | 2.20 | -73.8 | -22.2 | -0.44 |
| 2026-08-03 | OVID | 2.34 | -73.8 | -37.8 | -0.44 |
| 2026-08-04 | OVID | 2.34 | -73.8 | -37.8 | -0.44 |
| 2026-08-05 | OVID | 2.61 | -73.8 | -32.8 | -0.44 |
| 2026-08-06 | OVID | 2.66 | -73.8 | -32.3 | -0.44 |
| 2026-08-07 | OVID | 2.62 | -73.8 | -29.0 | -0.44 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-07-13 | OVID | -0.11 | 45.54 | 13.03 |
| 2026-07-14 | OVID | -0.11 | 45.54 | 13.03 |
| 2026-07-15 | OVID | -0.11 | 45.54 | 13.03 |
| 2026-07-16 | OVID | -0.11 | 45.54 | 13.03 |
| 2026-07-17 | OVID | -0.11 | 45.54 | 13.03 |
| 2026-07-20 | OVID | -0.11 | 45.58 | 13.03 |
| 2026-07-21 | OVID | -0.11 | 45.58 | 13.03 |
| 2026-07-22 | OVID | -0.11 | 45.58 | 13.03 |
| 2026-07-23 | OVID | -0.11 | 45.58 | 13.03 |
| 2026-07-24 | OVID | -0.11 | 45.58 | 13.03 |
| 2026-07-27 | OVID | -0.11 | 46.50 | 13.05 |
| 2026-07-28 | OVID | -0.11 | 46.50 | 13.05 |
| 2026-07-29 | OVID | -0.11 | 46.50 | 13.05 |
| 2026-07-30 | OVID | -0.11 | 46.50 | 13.05 |
| 2026-07-31 | OVID | -0.11 | 46.50 | 13.05 |
| 2026-08-03 | OVID | -0.11 | 56.15 | 13.05 |
| 2026-08-04 | OVID | -0.11 | 56.15 | 13.05 |
| 2026-08-05 | OVID | -0.11 | 56.15 | 13.05 |
| 2026-08-06 | OVID | -0.11 | 56.15 | 13.05 |
| 2026-08-07 | OVID | -0.11 | 56.15 | 13.05 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.12
Avg. EPS Est. Current Quarter
-0.1
Avg. EPS Est. Next Quarter
-0.11
Insider Transactions
-0.11
Institutional Transactions
56.15
Beta
0.25
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
25
Growth Score
40
Sentiment Score
96
Actual DrawDown %
37.6
Max Drawdown 5-Year %
-93.7
Target Price
5.75
P/E
Forward P/E
PEG
P/S
68.94
P/B
2.22
P/Free Cash Flow
EPS
-0.24
Average EPS Est. Cur. Y
-0.44
EPS Next Y. (Est.)
-0.44
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-339.31
Relative Volume
0.39
Return on Equity vs Sector %
-39.6
Return on Equity vs Industry %
-23.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
-29
◆
OVID
Healthcare
$2.63
Swing / Pullback
Buy the dip on strong trends
WATCH
RSI
58.5
Range 1M
70.7%
Sup Dist
1.1%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
-110%
EPS NY
-8.6%
52W%
82%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+118.6% upside
Upside
+118.6%
Quality
25
OVID — P/E HistoricalBiotechnology
Ovid Therapeutics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 23
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies; and OV4071, a first-in-human oral potassium-chloride cotransporter 2 direct activator which is in Phase 1 clinical trials for the treatment of psychosis associated with parkinson's disease, lewy body dementia, and acute schizophrenia. It has license and collaboration agreements with AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
OVID
Latest News
—
Caricamento notizie per OVID…
stock quote shares OVID – Ovid Therapeutics Inc. Stock Price stock today
news today OVID – Ovid Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch OVID – Ovid Therapeutics Inc. yahoo finance google finance
stock history OVID – Ovid Therapeutics Inc. invest stock market
stock prices OVID premarket after hours
ticker OVID fair value insiders trading